Carmen Bylund

Patient participation in cancer clinical trials (CCTs), is critical to the discovery of new treatments and medications.  CCTs are becoming a measure for quality cancer care, and therapies offered through clinical trials are being considered the preferred treatment choice for physicians and patients. But patient participation in CCTs remains low.…

Read more
Posted: April 7, 2020